Recently updated guidelines from the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) address the use of corticosteroids as an adjunct to antimicrobials for treatment of community-acquired pneumonia (CAP).1
Data showing a clinically significant mortality benefit of corticosteroids in the treatment of patients with severe CAP are limited. Some meta-analyses have found a reduced risk of death with corticosteroid use in such patients,2-4 but others have not,5,6 and the studies included in the meta-analyses varied in their quality and their definitions of severe CAP (Box).
Corticosteroids in Community-Acquired Pneumonia. JAMA. Published online February 06, 2020. doi:10.1001/jama.2020.0216
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: